Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

3-Methylhistidine excretion in myotonic dystrophy

Journal Article · · Neurology; (United States)
OSTI ID:5728776

3-Methylhistidine (3-MH) excretion reflects the rate of muscle protein catabolism, since 3-MH occurs almost exclusively in muscle actin and myosin and is not reutilized or catabolized. We studied 3-MH excretion in 9 patients with myotonic dystrophy, 8 normals, and 10 disease controls with Duchenne dystrophy and other disorders. 3-MH excretion was expressed relative to muscle mass as determined by both urinary creatinine and total body potassium (/sup 40/K method). Absolute 3-MH excretion was decreased in myotonic dystrophy patients but was normal when related to muscle mass. The finding of normal 3-MH excretion in myotonic dystrophy suggests that the muscle wasting in this disorder results from impaired anabolic processes rather than accelerated muscle destruction.

Research Organization:
Univ. of Rochester, NY
OSTI ID:
5728776
Journal Information:
Neurology; (United States), Journal Name: Neurology; (United States) Vol. 30:12; ISSN NEURA
Country of Publication:
United States
Language:
English